BIBLIO is the largest independent book marketplace in the world, with over 100 million books.

Skip to content

Label-Free Technologies For Drug Discovery
Stock photo: cover may vary

Label-Free Technologies For Drug Discovery

by Editor: Matthew Cooper (Institute for Molecular Bioscience, University of Queensland, Australia); Co-Editor: Lorenz M. Mayr (Biology Unit, Protease Platform, Novartis Pharma AG, Basel, Switzerland)

Add to wish list

Reader reviews for Label-Free Technologies For Drug Discovery

Details

  • Title Label-Free Technologies For Drug Discovery
  • Author Editor: Matthew Cooper (Institute for Molecular Bioscience, University of Queensland, Australia); Co-Editor: Lorenz M. Mayr (Biology Unit, Protease Platform, Novartis Pharma AG, Basel, Switzerland)
  • Binding unknown
  • Publisher John Wiley & Sons
  • ISBN 9780470979136

About the author

Dr Matthew Cooper, Institute for Molecular Bioscience, University of Queensland, Australia
Dr Cooper is a scientist and entrepreneur. He is Co-Founder and Chief Scientific Officer of Akubio Ltd; and Founder and Managing Director of Cambridge Medical Innovations. He has written more than 60 publications and invited reviews in leading scientific journals including Nature Biotechnology, Nature Cell Biology, and Nature Drug Discovery.

Dr Lorenz M. Mayr, Biology Unit, Protease Platform, Novartis Pharma AG, Basel, Switzerland
Dr Mayer is Head of the Biology Unit at the Protease Platform, Centre of Proteomic Chemistry (CPC), at Novartis Pharma AG with responsibility for target finding and target validation, protein expression, assay development and compound screening and profiling for all protease projects. Dr. Mayr is a member of several editorial and scientific advisory boards and also serves as a member at the Board of Directors of SBS, the Society of Biomolecular Sciences.